Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,481
Closed -$208K 112
2025
Q3
$208K Buy
+2,481
New +$204K 0.02% 99
2024
Q3
Sell
-1,736
Closed -$215K 105
2024
Q2
$215K Buy
1,736
+118
+7% +$15.2K 0.02% 85
2024
Q1
$213K Buy
+1,618
New +$199K 0.02% 84
2022
Q3
Sell
-5,885
Closed -$537K 74
2022
Q2
$537K Sell
5,885
-19
-0.3% -$1.68K 0.08% 39
2022
Q1
$484K Hold
5,904
0.06% 48
2021
Q4
$452K Hold
5,904
0.05% 53
2021
Q3
$443K Hold
5,904
0.05% 56
2021
Q2
$459K Sell
5,904
-132
-2% -$9.82K 0.05% 56
2021
Q1
$444K Buy
6,036
+113
+2% +$8.34K 0.06% 54
2020
Q4
$462K Hold
5,923
0.07% 49
2020
Q3
$469K Buy
5,923
+356
+6% +$27.9K 0.07% 45
2020
Q2
$411K Sell
5,567
-83
-1% -$6.25K 0.07% 43
2020
Q1
$415K Sell
5,650
-183
-3% -$14.4K 0.08% 42
2019
Q4
$506K Sell
5,833
-62
-1% -$5.09K 0.07% 48
2019
Q3
$474K Sell
5,895
-114
-2% -$9.14K 0.07% 41
2019
Q2
$481K Sell
6,009
-229
-4% -$17.5K 0.07% 41
2019
Q1
$473K Sell
6,238
-644
-9% -$48.2K 0.07% 39
2018
Q4
$502K Buy
6,882
+4
+0.1% +$282 0.09% 33
2018
Q3
$466K Buy
+6,878
New +$438K 0.06% 40

Other funds holding MRK

J.L. Bainbridge & Co's MRK Position: Q4 2025 in Review

J.L. Bainbridge & Co sold out of Merck (MRK) in Q4 2025, closing a stake of 2,481 shares — an estimated $208K sold.

J.L. Bainbridge & Co first reported a position in MRK in Q3 2018 and held it in 19 quarters. The position peaked at $537K in Q2 2022. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • J.L. Bainbridge & Co reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • J.L. Bainbridge & Co sold 2,481 Merck shares in Q4 2025, an estimated $208K.
  • J.L. Bainbridge & Co first reported a position in Merck in Q3 2018 and held it in 19 quarters.
  • J.L. Bainbridge & Co's Merck position peaked at $537K in Q2 2022.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on J.L. Bainbridge & Co's 13F filing for Q4 2025, filed 14 Jan 2026.